Shanghai, China · Founded 2020 · Privately Held (backing)
Developer of mRNA-based pharmaceutical products designed for nucleic acid-based therapeutics. Rongcan Biotech is based in Shanghai, China and was founded in 2020. It has raised $13.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$13.8M
Last round
—
Cap table — not yet on record
Rongcan Biotech's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Rongcan Biotech with a free account
·Watch Rongcan Biotech: the Monday email on marks, rounds and moves
